Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 129, Issue -, Pages 194-218Publisher
ELSEVIER
DOI: 10.1016/j.addr.2018.03.005
Keywords
Nanomaterials; Biomaterials; Advanced wound healing therapies; Current regulatory perspective
Categories
Funding
- Translational Medicine and Pharmacology
Ask authors/readers for more resources
Today, many of the newly developed pharmaceuticals and medical devices take advantage of nanotechnology and with a rising incidence of chronic diseases such as diabetes and cardiovascular disease, the number of patients afflicted globally with non-healing wounds is growing. This has created a requirement for improved therapies and wound care. However, converting the strategies applied in early research into new products is still challenging. Many of them fail to comply with the market requirements. This review discusses the legal and scientific challenges in the design of nanomedicines for wound healing. Are they lost in translation or is there a new generation of therapeutics in the pipeline? (C) 2018 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available